{
  "name": "Fluoxetine",
  "genericName": "fluoxetine",
  "brandNames": ["Prozac", "Sarafem"],
  "tags": ["SSRI", "Antidepressant"],
  "dosing": {
    "adult_acute": "20 mg once daily, may increase after 1 week",
    "adult_maintenance": "20-80 mg/day (MDD), 60-80 mg/day (OCD, Bulimia)",
    "notes": "Can be dosed once daily due to long half-life; weekly formulation available (Prozac Weekly 90mg)",
    "canadian_clinical": {
      "starting_dose": "10-20 mg once daily in the morning",
      "titration_schedule": "Increase by 10-20 mg every 1-2 weeks based on response",
      "max_dose_evidence": "80 mg/day (FDA max for MDD/OCD)",
      "max_dose_practice": "80 mg/day; rarely exceed due to long half-life",
      "inpatient_strategy": "Start 20 mg daily; can increase to 40-60 mg within 2-3 weeks for severe depression",
      "outpatient_strategy": "Start 10-20 mg; slow titration recommended; reassess at 4-6 weeks"
    }
  },
  "warnings": [
    "Black box warning: Increased suicidal thinking in children/adolescents/young adults",
    "Long half-life (4-6 days) means 5+ weeks to steady state; drug interactions persist weeks after discontinuation",
    "Significant CYP2D6 inhibitor - check drug interactions carefully",
    "Lower risk of discontinuation syndrome due to long half-life",
    "QTc prolongation risk at higher doses"
  ],
  "cautions": {
    "renal": "No adjustment needed",
    "hepatic": "Reduce dose or increase dosing interval in cirrhosis",
    "pregnancy": "Pregnancy Category C; some data suggests increased risk of cardiac defects; weigh risks/benefits"
  },
  "citations": ["APA Practice Guidelines for MDD (2010)", "CANMAT Depression Guidelines (2016)", "Prozac FDA Label"]
}
